Nektar Therapeutics Stock Price (NASDAQ:NKTR)

Add to My Stocks
$22.24 $0.07 (0.32%) NKTR stock closing price Jul 21, 2017 (Closing)
Prev Close* : $22.17
Market Cap:
Day Low: $21.98
52 Week Low: $11.41
Open: $22.19
Volume: 1871801
Day High: $22.82
52 Week High: $24.88

Latest Stock Market News

Latest Articles

Nektar Therapeutics News - From Partners

NKTR Stockcharts

View NKTR PE ratio, PS ratio stocks charts and compare with peers.
NKTR Chart
Note: Compare Nektar Therapeutics stock price history with the index and industry peers.

Nektar Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Nektar Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

NKTR Industry Peers

Company Price Change (%)
Avanir Pharma (AVNR)16.960 (0%)
Wuxi Pharmatech (WX)45.90.16 (0.35%)
Pfizer (PFE)33.480.06 (0.18%)
Progenics Pharma (PGNX)6.590 (0%)
Roche Holdings (RHHBY)32.270.07 (0.22%)
Bayer Ag (BAYRY)129.510.96 (0.74%)
Merck (MRK)62.630.31 (0.49%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.350.25 (6.1%)
Ignyta (RXDX)9.30.5 (5.68%)
PTC Therapeutics (PTCT)21.441.1 (5.41%)
Xencor (XNCR)23.780.78 (3.39%)
Adamis Pharma (ADMP)4.80.15 (3.23%)
Enanta Pharma (ENTA)37.471.05 (2.88%)
Tetraphase Pharmaceuticals (TTPH)8.090.22 (2.8%)
Top gainers from Medical-Drugs industry
* As of Jul 21, 2017
CompanyPriceChange (%)
Heron Therapeutics (HRTX)16.451.05 (6%)
Aralez Pharma (ARLZ)1.450.07 (4.61%)
ImmunoGen (IMGN)5.660.24 (4.07%)
Catalyst Pharma (CPRX)2.950.1 (3.28%)
Pacira Pharma (PCRX)47.651.5 (3.05%)
BioCryst Pharma (BCRX)5.410.16 (2.87%)
GlycoMimetics (GLYC)11.50.33 (2.79%)
Top losers from Medical-Drugs industry
* As of Jul 21, 2017

Nektar Therapeutics Stock News - Partner Headlines

4 Biotech Stocks to Watch   on Mar 22, 2017

Nektar Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues165.43M230.78M200.7M148.92M81.19M
Net Income-153.52M-81.17M-53.91M-162.01M-171.85M
Total Operating Expense248.07M226.04M188.65M230.54M191.95M
view Nektar Therapeutics income statement
balance sheet20162015201420132012
Total Assets568.87M502.06M441.62M434.52M497.79M
Total Liabilities480.74M495.63M405.28M524.43M450.77M
Shareholders Equity88.12M6.42M36.33M-89.9M47.01M
view Nektar Therapeutics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities7.93M-34.7M-116.42M90.58M1.6M
Net Cash From (Used By) Operating Activities-117.02M-73.08M-142M-38.52M-129.75M
Increase (Decrease) In Prop Plant And Equipment-6.39M-11.19M-9.97M-4.09M-10.58M
view Nektar Therapeutics cashflow statement

Nektar Therapeutics Stock Message Board

An investor needs to spend 22.17 to buy NKTR stock, as the closing Nektar Therapeutics stock price is 22.17. The total market value as denoted by 3.36B for Nektar Therapeutics, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Nektar Therapeutics stock analysis.

The terms stocks and shares mean the same thing. For Ex: Nektar Therapeutics stock price and Nektar Therapeutics share price mean the same thing. 1879344 NKTR shares were traded yesterday, and Nektar Therapeutics stock chart shows that the NKTR stock quote hit a day high of 22.5 and day low of 21.28. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Nektar Therapeutics does not pay dividends. Nektar Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.